Stay updated on Pembrolizumab for Refractory Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page's revision tag was updated from Revision: v3.5.3 to Revision: v3.5.4. This reflects a minor update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-05-15T14:24:04.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now shows an updated ClinicalTrials.gov site revision label (from v3.5.2 to v3.5.3), reflecting a version change for the website interface rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-04-24T05:46:38.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:38:41.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed. This appears to be a site version update with no impact on the study details or data.
    Difference
    0.1%
    Check dated 2026-03-19T06:10:31.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:34:32.000Z thumbnail image
  9. Check
    107 days ago
    Change Detected
    Summary
    Revision history updated from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-11T11:37:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Refractory Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.